SEACOR Marine Holdings Inc. (SMHI) Reaches $13.97 After 9.00% Up Move; Amphastar Pharmaceuticals (AMPH) Has 0.91 Sentiment

January 14, 2018 - By Nellie Frank

Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and sale of generic and proprietary injectable, inhalation, and intranasal products. The company has market cap of $853.31 million. It operates in two divisions, Finished Pharmaceutical Products and Active Pharmaceutical Ingredients. It currently has negative earnings. The companyÂ’s product portfolio comprises enoxaparin, a low molecular weight heparin that is used as an anticoagulant for prevention and treatment of deep vein thrombosis; naloxone for treating opioid overdose; Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency; Amphadase, a bovine-sourced hyaluronidase injection for the dispersion and absorption of other injected drugs; and lidocaine jelly, a local anesthetic product for urological procedures.

The stock of SEACOR Marine Holdings Inc. (NYSE:SMHI) is a huge mover today! The stock increased 3.87% or $0.52 during the last trading session, reaching $13.97. About 126,982 shares traded. SEACOR Marine Holdings Inc. (NYSE:SMHI) has 0.00% since January 14, 2017 and is . It has underperformed by 16.70% the S&P500.The move comes after 9 months positive chart setup for the $246.87M company. It was reported on Jan, 14 by We have $15.23 PT which if reached, will make NYSE:SMHI worth $22.22M more.

SEACOR Marine Holdings Inc. provides marine and support transportation services to offshore gas and oil exploration, development, and production facilities worldwide. The company has market cap of $246.87 million. It operates a fleet of offshore support and specialty vessels that deliver cargo and personnel to offshore installations; handle anchors and mooring equipment required to tether rigs to the seabed; tow rigs and assist in placing them on location and moving them between regions; and carry and launch equipment used underwater in drilling and well installation, maintenance, and repair. It currently has negative earnings. The firm is headquartered in Houma, Louisiana.

Analysts await Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) to report earnings on March, 12. They expect $-0.04 EPS, up 33.33% or $0.02 from last year’s $-0.06 per share. After $0.07 actual EPS reported by Amphastar Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -157.14% negative EPS growth.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: